RESEARCH PAPER
Effect of overweight and obesity on clinical course and prognosis in patients with acute coronary syndromes
More details
Hide details
1
Department of Public Health, Collegium Medicum, Jan Kochanowski University, Kielce, Poland
2
Department of Education and Research in Health Sciences, Faculty of Health Science, Medical University of Warsaw,Warsaw , Poland
3
Department of Public Health, Academy of Medical Sciences of Applied and Holistic Sciences, Warsaw, Poland
4
National Center for Health Policy and Research on Health Inequalities, Cardinal Stefan Wyszynski University, Warsaw, Poland
5
Departament of Medical Anthropology, Institute of Rural Health, Lublin, Poland
6
Chair of Neuropsychology and Neurorehabilitation, The Andrzej Frycz Modrzewski University, Kraków, Poland
7
Faculty of Medicine, Lazarski University, Warsaw, Poland
Corresponding author
Małgorzata Goździewska
Departament of Medical Anthropology, Institute of Rural Health, Lublin, Jaczewskiego 2, 20-090, Lublin, Poland
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
Acute coronary syndromes (ACS) are life-threatening conditions, characterized by limited or absent blood flow in the coronary arteries. Diagnosis of ACS depends on clinical symptoms, characteristic electrocardiogram (ECG) changes, and increased biochemical markers of myocardial necrosis above reference values. The aim of the study was to assess the effect of overweight and obesity on the clinical course and prognosis in patients with acute coronary syndromes.
Material and methods:
The study was conducted in the 2nd Cardiology Clinic in Kielce, south-east Poland. The study included 256 patients diagnosed with ACS, unstable angina (UA), non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI). Males constituted 58.6% of the total number of patients, and persons aged 65 and older – 51.2%. The study was of an observational, case-control character. The procedure covered anthropometric measurements, collection of fasting venous blood samples, and analysis of patients’ medical records.
Results:
The mean BMI in the examined population was 28.86(±4.85) kg/m2; mean body weight – 80.08(±16.03) kg; 41.8% of patients were diagnosed with overweight, 35.9% with obesity. The mean total cholesterol level in the examined population was 191.11(±51.28) mg/dL, and mean LVEF – 51.35 (±8.86)%. Coronary angiography was performed on 95.7% of patients. The most common risk factors for CVD were: arterial hypertension (65.6%), and hypercholesterolaemia (50.0%).
Conclusions:
Overweight or obesity increases the risk of occurrence of classical cardiovascular risk factors, such as arterial hypertension, hypercholesterolaemia, and type 2 diabetes. In patients with ACS, obesity was related with renal failure. In overweight and obese persons coronary angiography was most often performed.
REFERENCES (28)
1.
Ibanez B, James S, Agewall S, et al. Wytyczne ESC dotyczące postępowania w ostrym zawale serca z uniesieniem odcinka ST w 2017 roku. Kardiol Pol. 2018;76:229–313.
2.
Neumann FJ, Sousa-Uva M, Ahlsson A, et al. Wytyczne ESC/EACTS dotyczące rewaskularyzacji mięśnia sercowego (2018). Kardiol Pol. 2018;76:1585–1664.
4.
Hudzik B, Gąsior M. Ostre zespoły wieńcowe – postępy 2017/2018. Med Prakt. 2018;5:38–45.
5.
Cervellin G, Mattiuzzi C, Bovo C, Lippi G. Diagnostic algorithms for acute coronary syndrome-is one better than another? Ann Transl Med. 2016;4:193.
6.
Dobkowska-Chudoń W, Krupienicz A. Wieńcowe czynniki ryzyka – nieoczekiwane odkrycia. Med Rodz. 2016;1:32–36.
7.
Surma S, Szyndler A, Narkiewicz K. Świadomość nadciśnienia tętniczego i innych czynników ryzyka chorób układu sercowo-naczyniowego w populacji osób dorosłych. Choroby Serca i Naczyń 2018;15:14–22.
9.
Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol. 2016;23:NP1–NP96.
10.
Kwok CS, Pradhan A, Khan MA, et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014;173:20–28.
11.
El-Sheikh M, El Caidi NO, Kandiah A, et al. Associations of Obesity and Prognostic Nutritional Index on 1-Year Mortality in Patients with Acute Heart Failure. Card Fail Rev. 2025.
12.
Taha MB, Alansari H, Lazzara G, et al. The impact of obesity on cardiovascular diseases heart failure. Int Cardiovasc J. 2025.
13.
Xu F, Feng Y, Li J, et al. Exploring the obesity paradox in chronic respiratory disease: the mediating effect of triglyceride-glucose index on mortality. NPJ Prim Care Respir Med. 2025;35:41.
14.
Jóźwiak J, Tomasik T, Windak A. Rozpowszechnienie nadwagi i otyłości w Polsce na podstawie wyników badań LIPIDOGRAM 2004, LIPIDOGRAM 2006, LIPIDOGRAM 2015. Nutrition, Obesity & Metabolic Surgery 2017;9–10.
15.
World Health Organization. European regional obesity report 2024. Copenhagen: WHO Regional Office for Europe; 2024.
16.
NCD Risk Factor Collaboration (NCD-RisC). Rising trends in adult BMI globally and in Europe, including Poland. Lancet Global Health. 2023;11(9):e1302–e1310.
17.
Eurostat. Overweight and obesity – BMI statistics in EU countries. Eurostat Data Explorer. 2024.
18.
Chrysant SG, Chrysant GS. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens 2013;7:85–94.
19.
Abdulla J, Køber L, Abildstrøm SZ, et al. Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Eur Heart J 2008;29:594–601.
20.
Hou B, Mathai TS, Liu J, et al. Enhanced Muscle and Fat Segmentation for CT-Based Body Composition Analysis: A Comparative Study. arXiv preprint. 2024 Jan 10.
21.
Mueller TT, Zhou S, Starck S, et al. Body Fat Estimation from Surface Meshes using Graph Neural Networks. arXiv preprint. 2023 Jul 13.
22.
Starck S, Sideri-Lampretsa V, Ritter JJM, et al. Using UK Biobank data to establish population-specific atlases from whole body MRI. arXiv preprint. 2023.
23.
Zhang L, Chen Y, Hwang J, et al. Obesity and Rates of Coronary Angiography and PCI in Acute Coronary Syndromes: A Systematic Review and Meta-analysis. Eur Heart J Acute Cardiovasc Care. 2024;13(3):221–230.
24.
Stelzer A, Kraus D, Müller H, et al. Obesity and early invasive treatment in ACS: Insights from German multicenter registry. Clin Res Cardiol. 2023;112(9):1055–1063.
25.
Shaheen S, Ali SS, Hussain M, et al. Influence of Body Mass Index on In-hospital and 6-month Outcomes in Patients With Acute Coronary Syndrome Undergoing PCI. J Tehran Heart Cent. 2022;17(3):123–129.
26.
Guimarães PO, Soeiro AM, Ribeiro HB, et al. Obesity and prognosis in patients with acute coronary syndromes: insights from the Brazilian Registry of Acute Coronary Syndromes (ACCEPT). Int J Cardiol. 2021;334:38–43.
27.
Mehta PK, Wei J, Johnson BD, et al. Women with suspected ischemia and no obstructive coronary artery disease: clinical outcomes and prevalence of coronary microvascular dysfunction. Circulation. 2020;141(13):1044–1055.
28.
Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3(4):280–287.